SecFilingDex
DEF 14ABIAFCIK 0001712762

bioAffinity Technologies, Inc.

Proxy statement (DEF 14A) filed .

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Filing facts

Accession number
0001641172-25-013280
Filer
bioAffinity Technologies, Inc.
Ticker
BIAF
CIK
0001712762
Form type
DEF 14A
Form description
Proxy statement
Filed at
June 2, 2025
Period of report
2025-06-02
Filing size
14.6 MB
Last verified
August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.